Holen Sie sich die Stockscreener-App
83.59
0.49%
0.405
Handel nachbörslich:
83.68
0.085
+0.10%
Inhibrx Biosciences Inc Aktie (INBX) Neueste Nachrichten
Avoiding Lag: Real-Time Signals in (INBX) Movement - Stock Traders Daily
Insider Sell: Whats the beta of Inhibrx Biosciences Inc stockRecession Risk & Real-Time Volume Analysis - baoquankhu1.vn
Top Cybin (HELP) Competitors 2026 - MarketBeat
Does Stifel’s Focus on Ozekibart Milestones Reframe Inhibrx Biosciences' (INBX) Core Oncology Narrative? - simplywall.st
A Look At Inhibrx Biosciences (INBX) Valuation After Stifel Nicolaus Initiates Buy Coverage - Sahm
Weekly Recap: Is Inhibrx Biosciences Inc affected by consumer sentimentWeekly Earnings Recap & Real-Time Buy Signal Notifications - baoquankhu1.vn
This Inhibrx Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Sahm
Stifel initiates coverage of Inhibrx Biosciences (INBX) with buy recommendation - MSN
Inhibrx stock gains as Stifel issues new Buy (INBX:NASDAQ) - Seeking Alpha
Inhibrx Biosciences advances efforts targeting rare sarcoma cancers - Traders Union
INBX Should I Buy - Intellectia AI
Discipline and Rules-Based Execution in INBX Response - Stock Traders Daily
Inhibrx Biosciences (NASDAQ:INBX) Stock Price Down 5.7%What's Next? - MarketBeat
US Market Recap: Will Inhibrx Biosciences Inc stock recover after earnings2026 Risk Factors & Verified Momentum Watchlists - baoquankhu1.vn
Fundamentals Check: Will Inhibrx Biosciences Inc stock go up in YEAR2026 Opening Moves & Daily Volume Surge Signals - baoquankhu1.vn
Value Recap: Does Inhibrx Biosciences Inc have consistent dividend growthInsider Selling & Weekly Setup with ROI Potential - baoquankhu1.vn
Inhibrx Biosciences Inc. (INBX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Inhibrx Biosciences partners with Sarcoma Alliance to advance patient education resources - Traders Union
Retail Trends: Is Inhibrx Biosciences Inc stock undervalued right now2026 Earnings Impact & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Volume Recap: Is Inhibrx Biosciences Inc affected by consumer sentimentTrend Reversal & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Inhibrx Biosciences FY25 Review: Catalyst-Driven Hold Ahead Of Key 2026 Data (INBX) - Seeking Alpha
Ideas Watch: Is Inhibrx Biosciences Inc stock undervalued right nowEarnings Performance Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Inhibrx Biosciences (NASDAQ:INBX) Stock Price Down 6.6%Here's Why - marketbeat.com
Inhibrx Biosciences (INBX) Expected to Announce Earnings on Tuesday - MarketBeat
Behavioral Patterns of INBX and Institutional Flows - Stock Traders Daily
Inhibrx Biosciences Reports 2025 Financial Results - Intellectia AI
Inhibrx Reports Q4 Revenue of $0, Cash Balance at $124.2M - Intellectia AI
Inhibrx Biosciences Reports Q4 Earnings Miss - Intellectia AI
INBX SEC FilingsInhibrx Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Inhibrx Inc stock surges on Q4 2025 earnings and key 2026 pipeline milestones - ad-hoc-news.de
Inhibrx Biosciences, Inc. 2025 Annual Report – Clinical Pipeline, Regulatory Progress, and Company Overview - Minichart
Inhibrx Biosciences (NASDAQ:INBX) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Inhibrx Biosciences Q4 net loss narrows as expenses fall - TradingView
Inhibrx Biosciences 10-K: $1.3M revenue, EPS $(9.04) - TradingView
[10-K] Inhibrx Biosciences, Inc. Files Annual Report | INBX SEC FilingForm 10-K - Stock Titan
Inhibrx Biosciences (NASDAQ: INBX) details 2025 loss and 2026 trial plans - Stock Titan
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results - Nasdaq
Cancer drug filing tops Inhibrx milestones as cash reaches $124.2M - Stock Titan
Stock Analysis: Is Inhibrx Biosciences Inc a turnaround story2026 Key Lessons & High Accuracy Trade Alerts - baoquankhu1.vn
Boothbay Fund Management LLC Boosts Holdings in Inhibrx Biosciences, Inc. $INBX - marketbeat.com
Growth Value: What is Inhibrx Biosciences Incs P E ratio telling usQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
Latest INBX NewsInhibrx Announces Participation in Upcoming... - Stock Titan
Slotnik Capital LLC Sells 142,770 Shares of Inhibrx Biosciences, Inc. $INBX - MarketBeat
Inhibrx Biosciences Inc expected to post a loss of $2.08 a shareEarnings Preview - TradingView
(INBX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Inhibrx Biosciences : ESMO Sarcoma and Rare Cancers Congress 2026 (INBRX-109 in Ewing sarcoma Data Update Oral Presentation) - marketscreener.com
Market Trends: Is Inhibrx Biosciences Inc stock undervalued right now2026 Action & Growth Oriented Trade Recommendations - baoquankhu1.vn
Inhibrx Biosciences (INBX) to Release Quarterly Earnings on Monday - MarketBeat
Will Inhibrx Biosciences Inc stock recover after earnings2025 Key Lessons & Technical Pattern Based Buy Signals - baoquankhu1.vn
Inhibrx Announces Participation in Upcoming Scientific Conference - PR Newswire
How (INBX) Movements Inform Risk Allocation Models - Stock Traders Daily
INBX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Chondrosarcoma Treatment Market Forecasts Robust Growth During the Forecast Period (2026-2036) as Oncology Pipeline Strengthens | DelveInsight - The Malaysian Reserve
INBX Technical Analysis & ETF Price Forecast - Intellectia AI
INBX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Inhibrx Biosciences Highlights 2026 Pipeline and Strategy - The Globe and Mail
Market Leaders: Is Inhibrx Biosciences Inc stock undervalued right nowWeekly Loss Report & Reliable Price Action Trade Plans - baoquankhu1.vn
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):